Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,010 | 1,260 | 91.5% |
| Consulting Fee | $1,673 | 12 | 7.3% |
| Education | $271.36 | 41 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,120 | 130 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,777 | 291 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,907 | 99 | $0 (2024) |
| Pharming Healthcare, Inc. | $1,725 | 29 | $0 (2024) |
| CSL Behring | $1,480 | 104 | $0 (2024) |
| GENZYME CORPORATION | $945.32 | 43 | $0 (2024) |
| ABBVIE INC. | $930.95 | 47 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $892.70 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $814.43 | 83 | $0 (2023) |
| Amgen Inc. | $764.03 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,067 | 184 | AstraZeneca Pharmaceuticals LP ($802.62) |
| 2023 | $5,153 | 209 | Pharming Healthcare, Inc. ($1,314) |
| 2022 | $3,756 | 230 | Takeda Pharmaceuticals U.S.A., Inc. ($418.99) |
| 2021 | $2,864 | 210 | AstraZeneca Pharmaceuticals LP ($320.94) |
| 2020 | $1,742 | 107 | AstraZeneca Pharmaceuticals LP ($444.51) |
| 2019 | $1,964 | 149 | GlaxoSmithKline, LLC. ($359.65) |
| 2018 | $1,708 | 106 | AstraZeneca Pharmaceuticals LP ($342.93) |
| 2017 | $1,701 | 118 | Novartis Pharmaceuticals Corporation ($304.33) |
All Payment Transactions
1,313 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | ACTIMMUNE (Biological) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Bone/Inflammation/Rare Disease | ||||||
| 12/16/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Immunology and Neurology | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: PAIN | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: PAIN | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Immunology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Immunology | ||||||
| 11/27/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: GENETIC DISEASE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.52 | General |
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $39.94 | General |
| Category: BIOLOGIC | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | X4 Pharmaceuticals, Inc. | XOLREMDI (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 11/04/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,067 | 79,185 | $7.4M | $3.5M |
| 2022 | 28 | 1,282 | 78,499 | $7.0M | $3.3M |
| 2021 | 22 | 1,087 | 58,111 | $5.0M | $2.0M |
| 2020 | 25 | 1,135 | 58,678 | $5.0M | $1.8M |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1556 | Injection, immune globulin (bivigam), 500 mg | Office | 2023 | 65 | 49,728 | $5.8M | $2.8M | 47.9% |
| J2182 | Injection, mepolizumab, 1 mg | Office | 2023 | 21 | 11,600 | $436,200 | $269,461 | 61.8% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 11 | 5,518 | $569,704 | $189,189 | 33.2% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 15 | 5,475 | $297,825 | $148,884 | 50.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 402 | $60,300 | $36,394 | 60.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 73 | 766 | $76,600 | $34,221 | 44.7% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 69 | 1,538 | $53,865 | $22,309 | 41.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 45 | 581 | $20,405 | $6,264 | 30.7% |
| J1201 | Injection, cetirizine hydrochloride, 0.5 mg | Office | 2023 | 11 | 493 | $10,260 | $5,833 | 56.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 40 | 509 | $10,180 | $5,173 | 50.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $8,170 | $4,562 | 55.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 57 | 439 | $10,975 | $4,171 | 38.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 39 | $4,485 | $2,957 | 65.9% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 34 | 360 | $11,520 | $2,675 | 23.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 22 | 912 | $7,296 | $2,660 | 36.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 40 | $5,000 | $2,341 | 46.8% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 15 | $2,175 | $1,962 | 90.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 40 | 41 | $1,230 | $1,204 | 97.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 27 | $810.00 | $792.72 | 97.9% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 24 | 192 | $3,360 | $773.82 | 23.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 33 | 37 | $1,554 | $734.82 | 47.3% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 15 | 104 | $2,080 | $679.83 | 32.7% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 23 | 203 | $1,624 | $585.00 | 36.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 35 | 39 | $1,443 | $530.79 | 36.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 64 | 89 | $1,602 | $170.72 | 10.7% |
About Dr. Robert Hostoffer, DO
Dr. Robert Hostoffer, DO is a Allergy & Immunology healthcare provider based in Mayfield Heights, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730159674.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hostoffer, DO has received a total of $22,955 in payments from pharmaceutical and medical device companies, with $4,067 received in 2024. These payments were reported across 1,313 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($21,010).
As a Medicare-enrolled provider, Hostoffer has provided services to 4,571 Medicare beneficiaries, totaling 274,473 services with total Medicare billing of $10.5M. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Allergy
- Location Mayfield Heights, OH
- Active Since 01/24/2006
- Last Updated 01/02/2015
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1730159674
Products in Payments
- NUCALA (Biological) $1,631
- DUPIXENT (Biological) $1,515
- JOENJA (Drug) $1,250
- XOLAIR (Biological) $1,175
- TEZSPIRE (Biological) $929.03
- Haegarda (Biological) $794.82
- TRELEGY ELLIPTA (Drug) $773.83
- FASENRA (Biological) $707.98
- Hizentra (Biological) $663.87
- TAKHZYRO (Biological) $632.99
- FASENRA (Drug) $624.57
- Xhance (Drug) $588.96
- PANZYGA (Biological) $505.00
- RUCONEST (Biological) $475.35
- ACTIMMUNE (Drug) $460.46
- UBRELVY (Drug) $455.92
- Xolair (Biological) $449.52
- AUVI-Q (Drug) $439.90
- AirDuo Digihaler (Drug) $433.71
- XOLAIR (Drug) $431.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.